Kudo, Y.; Suzuki, H.; Tanaka, T.; Kaneko, M.K.; Kato, Y.
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas. Antibodies 2023, 12, 31.
https://doi.org/10.3390/antib12020031
AMA Style
Kudo Y, Suzuki H, Tanaka T, Kaneko MK, Kato Y.
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas. Antibodies. 2023; 12(2):31.
https://doi.org/10.3390/antib12020031
Chicago/Turabian Style
Kudo, Yuma, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K. Kaneko, and Yukinari Kato.
2023. "Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas" Antibodies 12, no. 2: 31.
https://doi.org/10.3390/antib12020031
APA Style
Kudo, Y., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y.
(2023). Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas. Antibodies, 12(2), 31.
https://doi.org/10.3390/antib12020031